Since we last provided an update earlier this month on the proposed settlements put forth by the parties in the PFAS AFFF MDL, a few significant steps forward have been taken towards finalizing the settlements by year end. In June 2023, news outlets of all varieties...
2023 has proven to be an extremely busy year for PFAS state AG lawsuits seeking environmental pollution remediation costs from PFAS manufacturers and AFFF manufacturers. We previously wrote regarding Illinois (February), Maine (April), Kentucky (April), Rhode Island,...
As we have note in prior posts, the Biden administration and the EPA have been emphasizing environmental justice, including a stronger focus on the negative health effects of Ethylene Oxide (EtO), an industrial solvent widely used as a sterilizing agent for medical...
In 2021, we discussed how a Delaware federal court weighed in as to whether or not Delaware tort law recognized a viable cause of action based on fear of cancer resulting from Ethylene Oxide (EtO) emissions (holding that it did not). In that decision, Judge Stephanos...
On September 13, 2023, John Gardella will host an invitation-only luncheon discussion at the iGlobal Forum conference in Manhattan. The session, titled "From ESG to Es+G: Understanding Future Environmental Risks To ESG Rating and How To Integrate Future Risk...
On several occasions, we wrote regarding a Michigan state court ruling that struck down Michigan’s PFAS regulations related to drinking water enforceable limits, with the ensuing appeal in December 2022 by the state. We last updated that at recent oral arguments on...
Attorney John Gardella was recently interviewed by Hayleigh Colombo, writer for The Buffalo News, for her article regarding PFAS costs and remediation issues for New York's drinking water sources. The article examines the steps that New York is taking to address PFAS...
Attorney John Gardella was recently interviewed by Carey Gillam, contributing writer for The Guardian and Managing Editor of The New Lede publication, for her article regarding the ongoing debate surrounding PFAS and CERCLA liability. The article examines the impacts...
Last year, we wrote regarding a recommendation by the National Academy of Sciences (NAS) to offer patients PFAS blood testing for patients suspected to have had high levels of PFAS exposure. Now, several politicians are taking the NAS recommendations one step further...
Perhaps unsurprising to those entrenched in PFAS issues, the EPA issued a memorandum today in which it clearly delineates PFAS EPA enforcement as a priority of the agency for the remainder of 2023 and into 2024. While the last couple of years have seen unprecedented...